Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin

키워드

참고문헌 (30)

1. Falanga A, "Mechanisms and risk factors of thrombosis in cancer", Crit Rev Oncol Hematol, 118, pp.79~83 (2017)
2. Haddad TC, "Chemotherapy-induced thrombosis", Thromb Res, 118, pp.555~568 (2006)
3. Heit JA, "Risk factors for deep vein thrombosis and pulmonary embolism : a population-based case-control study", Arch Intern Med, 160, pp.809~815 (2000)
4. Blom JW, "Malignancies, prothrombotic mutations, and the risk of venous thrombosis", JAMA, 293, pp.715~722 (2005)
5. 이윤규, "Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer", Cancer Research and Treatment, 47(4), pp.670~675 (2015), 대한암학회[DOI]
6. Mellema WW, "Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy", Lung Cancer, 86, pp.73~77 (2014)
7. Numico G, "Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine", Cancer, 103, pp.994~999 (2005)
8. Moore RA, "High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy : a large retrospective analysis", J Clin Oncol, 29, pp.3466~3473 (2011)
9. Seng S, "Risk of venous thromboembolism in patients with cancer treated with cisplatin : a systematic review and meta-analysis", J Clin Oncol, 30, pp.4416~4426 (2012)
10. Chew HK, "Incidence of venous thromboembolism and its effect on survival among patients with common cancers", Arch Intern Med, 166, pp.458~464 (2006)
11. Kuderer NM, "Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy", J Clin Oncol, 26(15_suppl), pp.9521~ (2008)
12. Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)
13. Siegel RL, "Cancer statistics, 2018", CA Cancer J Clin, 68, pp.7~30 (2018)
14. Porceddu SV, "Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma", Int J Radiat Oncol Biol Phys, 60, pp.365~373 (2004)
15. Bernier J, "Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer", N Engl J Med, 350, pp.1945~1952 (2004)
16. Adelstein DJ, "An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer", J Clin Oncol, 21, pp.92~98 (2003)
17. Forastiere AA, "Long-term results of RTOG 91-11 : a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer", J Clin Oncol, 31, pp.845~852 (2013)
18. Haen P, "Thrombosis risk associated with head and neck cancer : a review", Int J Mol Sci, 20, pp.2838~ (2019)
19. Paneesha S, "Frequency, demographics and risk(according to tumour type or site)of cancer-associated thrombosis among patients seen at outpatient DVT clinics", Thromb Haemost, 103, pp.338~343 (2010)
20. Kakei Y, "Incidence of venous thromboembolism after oral oncologic surgery with simultaneous reconstruction", J Oral Maxillofac Surg, 74, pp.212~217 (2016)
21. Sorensen JB, "Performance status assessment in cancer patients : an inter-observer variability study", Br J Cancer, 67, pp.773~775 (1993)
22. Khorana AA, "Development and validation of a predictive model for chemotherapy-associated thrombosis", Blood, 111, pp.4902~4907 (2008)
23. Lydiatt WM, "Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual", CA Cancer J Clin, 67, pp.122~137 (2017)
24. Kroger K, "Risk factors for venous thromboembolic events in cancer patients", Ann Oncol, 17, pp.297~303 (2006)
25. Khorana AA, "Incidence and predictors of venous thromboembolism(VTE)among ambulatory high-risk cancer patients undergoing chemotherapy in the United States", Cancer, 119, pp.648~655 (2013)
26. Lu CF, "Increased procoagulant activity of red blood cells in the presence of cisplatin", Chin Med J(Engl), 121, pp.1775~1780 (2008)
27. Jafri M, "Cisplatin-associated thrombosis", Anticancer Drugs, 19, pp.927~929 (2008)
28. Walsh J, "Modulation of tissue factor on human monocytes by cisplatin and adriamycin", Br J Haematol, 81, pp.480~488 (1992)
29. Chew HK, "The incidence of venous thromboembolism among patients with primary lung cancer", J Thromb Haemost, 6, pp.601~608 (2008)
30. Aonuma AO, "Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy : a single-institutional retrospective cohort analysis(Sapporo CAT study)", BMJ Open, 9, pp.e028563~ (2019)

관련 논문AI추천